Patients with Demodex blepharitis show significantly higher rates of microbial co-infestation than healthy controls.
IRVINE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced financial results for the fourth quarter and full-year ended December 31, 2025, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results